128 related articles for article (PubMed ID: 14531561)
1. Implantable drug-releasing biodegradable microspheres for local treatment of brain glioma.
Menei P; Benoit JP
Acta Neurochir Suppl; 2003; 88():51-5. PubMed ID: 14531561
[TBL] [Abstract][Full Text] [Related]
2. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study.
Menei P; Venier MC; Gamelin E; Saint-André JP; Hayek G; Jadaud E; Fournier D; Mercier P; Guy G; Benoit JP
Cancer; 1999 Jul; 86(2):325-30. PubMed ID: 10421269
[TBL] [Abstract][Full Text] [Related]
3. Intracavitary chemotherapy for glioblastoma: present status and future directions.
Westphal M; Lamszus K; Hilt D
Acta Neurochir Suppl; 2003; 88():61-7. PubMed ID: 14531563
[TBL] [Abstract][Full Text] [Related]
4. Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.
Menei P; Jadaud E; Faisant N; Boisdron-Celle M; Michalak S; Fournier D; Delhaye M; Benoit JP
Cancer; 2004 Jan; 100(2):405-10. PubMed ID: 14716778
[TBL] [Abstract][Full Text] [Related]
5. Editors' remarks: Evolving concepts for local therapies for glioma.
Westphal M; Tonn JC
Acta Neurochir Suppl; 2003; 88():VII-IX. PubMed ID: 14531552
[No Abstract] [Full Text] [Related]
6. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
[TBL] [Abstract][Full Text] [Related]
7. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
[TBL] [Abstract][Full Text] [Related]
8. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
Yuan X; Dillehay LE; Williams JR; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
[TBL] [Abstract][Full Text] [Related]
9. [Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].
Landolt AM
Acta Neurochir (Wien); 1971; 24(4):263-8. PubMed ID: 4332090
[No Abstract] [Full Text] [Related]
10. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial.
Menei P; Capelle L; Guyotat J; Fuentes S; Assaker R; Bataille B; François P; Dorwling-Carter D; Paquis P; Bauchet L; Parker F; Sabatier J; Faisant N; Benoit JP
Neurosurgery; 2005 Feb; 56(2):242-8; discussion 242-8. PubMed ID: 15670372
[TBL] [Abstract][Full Text] [Related]
11. Local chemotherapy with cisplatin-depot for glioblastoma multiforme.
Sheleg SV; Korotkevich EA; Zhavrid EA; Muravskaya GV; Smeyanovich AF; Shanko YG; Yurkshtovich TL; Bychkovsky PB; Belyaev SA
J Neurooncol; 2002 Oct; 60(1):53-9. PubMed ID: 12416546
[TBL] [Abstract][Full Text] [Related]
12. Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization.
Roullin VG; Mege M; Lemaire L; Cueyssac JP; Venier-Julienne MC; Menei P; Gamelin E; Benoit JP
Pharm Res; 2004 Sep; 21(9):1558-63. PubMed ID: 15497679
[TBL] [Abstract][Full Text] [Related]
13. The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers.
Brem H; Lawson HC
Cancer; 1999 Jul; 86(2):197-9. PubMed ID: 10421254
[No Abstract] [Full Text] [Related]
14. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults.
Matsutani M; Nakamura O; Nakamura M; Nagashima T; Asai A; Fujimaki T; Tanaka H; Ueki K; Tanaka Y
J Neurooncol; 1994; 19(3):227-37. PubMed ID: 7807173
[TBL] [Abstract][Full Text] [Related]
16. Stereotaxic interstitial irradiation of malignant brain tumors.
Gutin PH; Leibel SA
Neurol Clin; 1985 Nov; 3(4):883-93. PubMed ID: 3001493
[TBL] [Abstract][Full Text] [Related]
17. Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice.
Cardinale RM; Dillehay LE; Williams JA; Tabassi K; Brem H; Lee DJ
Radiat Oncol Investig; 1998; 6(2):63-70. PubMed ID: 9572682
[TBL] [Abstract][Full Text] [Related]
18. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma.
Chang EL; Loeffler JS; Riese NE; Wen PY; Alexander E; Black PM; Coleman CN
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):65-70. PubMed ID: 9422559
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in the medical treatment of glioma-temozolomide].
Nishikawa R
No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
[No Abstract] [Full Text] [Related]
20. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
